Altai Protocol Library New Protocol: Ivonescimab with Chemotherapy for Untreated Advanced Squamous NSCLC U. Darda Bayraktar, MD 2025-11-15
Altai Protocol Library New Protocol: Inotuzumab Ozogamicin Then Blinatumomab for Older Adults with Ph-Negative ALL U. Darda Bayraktar, MD 2025-11-15
Altai Protocol Library New Protocol: Glofitamab Plus Polatuzumab Vedotin for Relapsed/Refractory Large B-Cell Lymphoma U. Darda Bayraktar, MD 2025-11-15
Altai Protocol Library New Indication: Sacituzumab Govitecan for Untreated Advanced Triple Negative Breast Cancer U. Darda Bayraktar, MD 2025-11-14
Altai Protocol Library New Reference: 9-Year Results for Adjuvant Nivolumab in Melanoma U. Darda Bayraktar, MD 2025-11-14
Altai Protocol Library New Indication: Belzutifan for Advanced Pheochromocytoma or Paraganglioma U. Darda Bayraktar, MD 2025-11-14
Altai Protocol Library New Protocol: Capivasertib with Abiraterone for PTEN-Deficient Prostate Cancer U. Darda Bayraktar, MD 2025-11-14
Altai Protocol Library New Indication: Adjuvant Atezolizumab for ctDNA-Positive Bladder Cancer U. Darda Bayraktar, MD 2025-11-14
Altai Protocol Library New Drug: Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer U. Darda Bayraktar, MD 2025-11-13
Altai Protocol Library New Reference: Neoadjuvant Carboplatin for Triple-Negative Breast Cancer U. Darda Bayraktar, MD 2025-11-13
